Beacon pharmaceuticals limited бангладеш

Beacon Pharmaceuticals Ltd.manufactures and markets pharmaceutical finished formulation products and intravenous fluids and has core focus on manufacturing specialized and sophisticated anti-cancer and bio-tech products; cardiovascular drugs, antibiotics, NSAIDs and other life saving medicines. The company was established in 2001 and is located in Dhaka.

Basic Information

Total Employees:

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Outstanding Shares:

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Registered Capital:

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Financial Auditors:

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Key Executives

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Chief Financial Officer

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Chairman of the Board

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Director

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Director

Purchase the Beacon Pharmaceuticals Ltd report to view the information.

Director

Ownership Details

Company Performance

Financial values in the chart are available after Beacon Pharmaceuticals Ltd report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 125 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency BDT. Absolute financial data is included in the purchased report.

Net sales revenue

28.93%

Total operating revenue

28.96%

Operating profit (EBIT)

22.04%

Net Profit (Loss) for the Period

67.46%

Operating Profit Margin (ROS)

-0.4%

Net Profit Margin

0.81%

Return on Equity (ROE)

1.11%

Debt to Equity Ratio

-0.72%



Source: www.emis.com

Добавить комментарий

Ваш e-mail не будет опубликован. Обязательные поля помечены *